In the pipeline from march 14.AEZS and the Julius-Maximilius University of Wurzburg had announce a licence agreement of six months for the development of a potential "Oral Prophylactic vaccin".Now were are more than 3 months later and we can see some others developments like DOSE,who wants develope on the same theme.Competition is a singht of market interest,and it could upgrade the real interest of the AEZS investers in the potential of this agreement for the next months.GLTA.